Role of the PD-1 and PD-L1 axis in COVID-19.
Srinivisa Reddy BonamHaitao HuJagadeesh BayryPublished in: Future microbiology (2022)
Tweetable abstract Severe COVID-19 patients display dysregulated expression of checkpoint molecules PD-1 and its ligand PD-L1, suggesting that these checkpoint molecules could be considered as prognostic markers and therapeutic targets in severe cases of COVID-19.